Individuals with schizophrenia have experienced an increase in psychiatric, medical, and treatment risks because of the COVID-19 pandemic.
Stephen Gibson, PharmD, Rph
Advertisement
Articles by Stephen Gibson, PharmD, Rph
How can patient-centered, collaborative care help promote safety and stabilization in the treatment of patients with cooccurring diagnoses of schizophrenia and COVID-19?
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Dangers of Conversion Therapy: What Chiles v Salazar Could Mean for LGBTQ+ Youth
2
Candy and Other Food Treats or Tricks
3
Positive FDA Meeting for Abuse Deterrent Fentanyl Patch
4
Beyond Survival: Understanding the Long Road to Stroke Recovery
5
